Zeo ScientifiX Files 8-K Report
Ticker: ZEOX · Form: 8-K · Filed: 2026-04-07T07:50:14-04:00
Sentiment: neutral
Topics: regulatory-filing, 8-K
TL;DR
Zeo ScientifiX filed a routine 8-K, check exhibits for details.
AI Summary
Zeo ScientifiX, Inc. filed an 8-K report on April 7, 2026, primarily detailing "Other Events" under Item 8.01 and including financial statements and exhibits under Item 9.01. The filing does not contain specific financial figures or significant business developments beyond its routine reporting nature.
Why It Matters
This 8-K filing indicates Zeo ScientifiX is meeting its regulatory reporting obligations. Investors should review the exhibits for any material updates not explicitly detailed in the summary.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report without immediate indications of significant financial changes or material events.
Key Numbers
- 26166 — 8-K iXBRL Size (Size of the main 8-K document in KB.)
- 22685 — Exhibit 99.1 Size (Size of Exhibit 99.1 in KB.)
Key Players & Entities
- Zeo ScientifiX, Inc. (company) — Filer of the 8-K report
- 0001557376 (company) — CIK number for Zeo ScientifiX, Inc.
- 0001829126-26-003240 (company) — SEC Accession Number for the filing
- 2026-04-07 (date) — Filing Date and Period of Report
FAQ
What specific 'Other Events' are detailed in Item 8.01 of the filing?
The provided filing summary does not detail the specific 'Other Events' mentioned in Item 8.01; this information would be found within the full document or its exhibits.
What is the purpose of Item 9.01 in this 8-K filing?
Item 9.01 pertains to Financial Statements and Exhibits, indicating that the filing includes these components.
When was this 8-K report filed with the SEC?
The 8-K report was filed on April 7, 2026.
What is the CIK number for Zeo ScientifiX, Inc.?
The CIK number for Zeo ScientifiX, Inc. is 0001557376.
What is the SIC code listed for Zeo ScientifiX, Inc.?
The SIC code listed is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Stats: 461 words · 2 min read · ~2 pages · Grade level 10.4 · Accepted 2026-04-07 07:50:14
Filing Documents
- zeoscientifix_8k.htm (8-K) — 26KB
- zeoscientifix_ex99-1.htm (EX-99.1) — 22KB
- 0001829126-26-003240.txt ( ) — 208KB
- ocel-20260407.xsd (EX-101.SCH) — 3KB
- ocel-20260407_lab.xml (EX-101.LAB) — 33KB
- ocel-20260407_pre.xml (EX-101.PRE) — 22KB
- zeoscientifix_8k_htm.xml (XML) — 3KB
01 Other Events
Item 8.01 Other Events. On April 7, 2026, ZEO issued a press release announcing its selection as a Qualified Team advancing into the Semi-Finals stage of the XPRIZE Healthspan competition. A copy of the press release is included as Exhibit 99.1 to this Report.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated April 7, 2026 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: April 7, 2026 ZEO SCIENTIFIX, INC. By: /s/ Ian T. Bothwell Ian T. Bothwell Chief Executive Officer and Chief Financial Officer 2